(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.30%) $79.19
(-1.08%) $2.01
(0.22%) $2 314.60
(0.49%) $26.96
(0.53%) $967.70
(-0.06%) $0.932
(-0.08%) $10.98
(-0.15%) $0.797
(1.51%) $92.51
5.02% $ 2.93
@ $3.65
Emitido: 14 feb 2024 @ 09:30
Retorno: -19.77%
Señal anterior: feb 12 - 15:55
Señal anterior:
Retorno: -6.48 %
Live Chart Being Loaded With Signals
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases...
Stats | |
---|---|
Volumen de hoy | 1.11M |
Volumen promedio | 1.73M |
Capitalización de mercado | 431.79M |
EPS | $0 ( 2024-05-01 ) |
Próxima fecha de ganancias | ( $-0.340 ) 2024-06-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.880 |
ATR14 | $0.00900 (0.31%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-12 | Neupert Peter M | Buy | 15 000 | Common Stock |
2024-03-12 | Neupert Peter M | Sell | 15 000 | Stock Option (right to buy) |
2024-03-04 | Pellini Michael J | Buy | 31 328 | Common Stock |
2024-03-04 | Pellini Michael J | Buy | 48 044 | Stock Option (right to buy) |
2024-03-04 | Owen Katey Einterz | Buy | 31 328 | Common Stock |
INSIDER POWER |
---|
61.57 |
Last 100 transactions |
Buy: 4 473 782 | Sell: 1 037 795 |
Volumen Correlación
Adaptive Biotechnologies Correlación
10 Correlaciones Más Positivas | |
---|---|
MNRO | 0.955 |
TNYA | 0.95 |
OTLY | 0.95 |
GOODM | 0.948 |
RENT | 0.944 |
NGM | 0.943 |
LYT | 0.943 |
NVCR | 0.943 |
SPI | 0.941 |
CTSO | 0.941 |
10 Correlaciones Más Negativas | |
---|---|
SKYA | -0.953 |
HERA | -0.948 |
BRIV | -0.942 |
LDHA | -0.94 |
AGGR | -0.939 |
HERAU | -0.939 |
ISEE | -0.939 |
CRZN | -0.938 |
TBSAU | -0.938 |
PRSR | -0.937 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Adaptive Biotechnologies Correlación - Moneda/Commodity
Adaptive Biotechnologies Finanzas
Annual | 2023 |
Ingresos: | $170.28M |
Beneficio Bruto: | $72.49M (42.57 %) |
EPS: | $-1.560 |
FY | 2023 |
Ingresos: | $170.28M |
Beneficio Bruto: | $72.49M (42.57 %) |
EPS: | $-1.560 |
FY | 2022 |
Ingresos: | $185.31M |
Beneficio Bruto: | $127.40M (68.75 %) |
EPS: | $-1.000 |
FY | 2021 |
Ingresos: | $154.34M |
Beneficio Bruto: | $105.04M (68.06 %) |
EPS: | $-1.580 |
Financial Reports:
No articles found.
Adaptive Biotechnologies
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID for the confirmation of past COVID-19 infection. It also provides clonoSEQ, a clinical diagnostic product for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B cell acute lymphoblastic leukemia, and chronic lymphocytic leukemia, as well as available as a CLIA-validated laboratory developed test for patients with other lymphoid cancers; and immunoSEQ T-MAP COVID for vaccine developers and researchers to measure the T-cell immune response to vaccines. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. It serves the life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico